Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 29;16(10):1383.
doi: 10.3390/ph16101383.

Impact of Solidago virgaurea Extract on Biofilm Formation for ESBL- Pseudomonas aeruginosa: An In Vitro Model Study

Affiliations

Impact of Solidago virgaurea Extract on Biofilm Formation for ESBL- Pseudomonas aeruginosa: An In Vitro Model Study

Ali Hazim Abdulkareem et al. Pharmaceuticals (Basel). .

Abstract

The increasing disparity between antimicrobial resistance (AMR) and the development of new antimicrobials continues to pose a significant global health concern. However, plant extracts have shown promise in combating this issue either through their inherent antimicrobial activity or by serving as potential reservoirs of effective antimicrobial compounds. These compounds have the ability to target pathogenic biofilms and inhibit the production of extended-spectrum β -lactamases (ESBLs). However, there is limited research available on the antibacterial properties of goldenrod extract. Thus, the objective of this study was to investigate the impact of S. virgaurea (SV) extract on the viability and ability to form biofilms of ESBL-Pseudomonas aeruginosa (P. aeruginosa). A cross-sectional study was conducted from August 2022 to March 2023. The broth microdilution method was employed to determine the minimum inhibitory concentration (MIC) of the (SV) extract. Subsequently, the minimum bactericidal concentration (MBC) was determined based on the MIC values obtained. The antibiotic susceptibility of bacteria was evaluated using the Kirby disk diffusion assay and an Antimicrobial Susceptibility Testing (AST) card in conjunction with the Vitek-2 compact system. Biofilm formation was evaluated using Congo red and a 96-well Elisa plate, while the presence of extended-spectrum β-lactamases (ESBLs) was estimated by measuring the reduction of nitrocefin at a wavelength of 390 nm. In addition, treatment of biofilm and ESBL activity with SV extract using 96-well Elisa plate and nitrocefin hydrolyzing, respectively. The resistance rates of P. aeruginosa isolates to the tested antibiotics were as follows: Levofloxacin 33%, Ciprofloxacin 40%, Amikacin 49%, Meropenem 50%, Cefepime 70%, Ceftazidime 75%, Cefotaxime 85%, Piperacillin-Tazobactam 90%, Amoxiclav 97%, Ampicillin 99%, Ceftriaxone 100%. The prevalence of MDR-P. aeruginosa, XDR-P. aeruginosa, PDR-P. aeruginosa and non-MDR-PA were 40% (n = 40), 7% (n = 7), 3% (n = 3) and 50% (n = 50), respectively. From the GC-MS results, it was observed that the presence of Octadecane, Clioquinol, Glycerol tricaprylate, hexadecanoic acid, cis-13-octadecenoic acid, oleic acid and Propanamide were the major components in the Solidago extract. In the determination of plant crude extracts, the values ranged between 0.25 and 64 mg/mL against bacteria. The resulting activity of the extract showed a significant statistical relationship at a p-value ≤ 0.01 against ESBL production and biofilm formation in P. aeruginosa. The S. virgaurea extract exhibited effectiveness in inhibiting biofilm formation and combating P. aeruginosa strains that produce extended-spectrum β-lactamases (ESBLs).

Keywords: Antimicrobial resistance; Biofilm; ESBLs; MDR; Pseudomonas aeruginosa; Solidago.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mechanisms of antibiotic resistance in P. aeruginosa. Reprinted/adapted with permission from Ref. [5]. 2022, Qin, S.; Xiao, W.; Zhou, C.; Pu, Q.; Deng, X.; Lan, L.; Liang, H.; Song, X.; Wu, M.
Figure 2
Figure 2
Distribution of P. aeruginosa based on source.
Figure 3
Figure 3
Percentage of antibiotic resistant P. aeruginosa.
Figure 4
Figure 4
Kirby–Bauer Disk Diffusion Susceptibility Test for antibiotics in P. aeruginosa. No inhibition zone: Full resistance; Greenish-colored: producing of pyocyanin pigment by P. aeruginosa.
Figure 5
Figure 5
Congo red method to detect biofilm formation in P. aeruginosa. Black colonies as positive for biofilm.
Figure 6
Figure 6
GC–MS analysis of SV extract.
Figure 7
Figure 7
Effect of goldenrod herb against ESBL producing P. aeruginosa. ***: strong significant.
Figure 8
Figure 8
Anti-biofilm producing P. aeruginosa. ***: strong significant.
Figure 9
Figure 9
Summary of methods under this study. This image was designed in this study by researcher Mohammed Mukhles Ahmed.
Figure 10
Figure 10
Identification of P. aueroginosa. This image was designed in this study by researcher Mohammed Mukhles Ahmed.
Figure 11
Figure 11
Maceration extraction of golden rod herb. This image was designed in this study by researcher Mohammed Mukhles Ahmed.

Similar articles

Cited by

References

    1. Al Maeni S.A.L., Ahmed M.M., Abed A.D., Abbas R.H., Jassim S.A.A., Mohamad A.M. Extraction and Purification of Staphylolysin Enzyme from Local Isolate of Pseudomonas aeruginosa. Ann. Rom. Soc. Cell Biol. 2021;25:1201–1208.
    1. Rossi E., La Rosa R., Bartell J.A., Marvig R.L., Haagensen J.A.J., Sommer L.M., Molin S., Johansen H.K. Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat. Rev. Microbiol. 2021;19:331–342. doi: 10.1038/s41579-020-00477-5. - DOI - PubMed
    1. Seder N., Rayyan W.A., Al-Fawares M.H.O., Bakar A. Pseudomonas aeruginosa Virulence Factors and Antivirulence mechanisms to Combat Drug Resistance; A Systematic Review. Mortality. 2023;10:11.
    1. Darby E.M., Trampari E., Siasat P., Gaya M.S., Alav I., Webber M.A., Blair J.M.A. Molecular mechanisms of antibiotic resistance revisited. Nat. Rev. Microbiol. 2023;21:280–295. doi: 10.1038/s41579-022-00820-y. - DOI - PubMed
    1. Qin S., Xiao W., Zhou C., Pu Q., Deng X., Lan L., Liang H., Song X., Wu M. Pseudomonas aeruginosa: Pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct. Target. Ther. 2022;7:199. doi: 10.1038/s41392-022-01056-1. - DOI - PMC - PubMed

Grants and funding

This research received no external funding.

LinkOut - more resources